Tumours: definition, classification and tumorigenesis
State exam topic 33: how tumours are defined and classified, and the theories of how they form.
Exam Prep · State examSurgery · Surgical oncology
Tumors – Definition, Classification, and Theories of Tumorigenesis
1. Definition of a Tumor (Neoplasm)
- Tumor / Neoplasm: an abnormal mass of tissue
- Growth is:
- Excessive
- Uncoordinated with normal tissues
- Persistent after removal of the initiating stimulus
- Term applies to both benign and malignant lesions
- Key concept: loss of normal growth control
Distinction
- Tumor ≠ inflammation, hyperplasia, or regeneration
- Hyperplasia: controlled, reversible increase in cell number
- Neoplasia: autonomous, irreversible growth
2. General Characteristics of Neoplasms
Cellular Characteristics
- Clonality: tumor arises from a single transformed cell
- Altered cell cycle regulation
- Genomic instability
- Progressive accumulation of mutations
Biological Behavior
- Benign tumors:
- Localized growth
- Well differentiated
- No metastasis
- Malignant tumors:
- Invasive growth
- Destruction of surrounding tissues
- Ability to metastasize
3. Classification of Tumors
A. Classification According to Biological Behavior
Benign Tumors
- Slow-growing
- Well circumscribed
- Often encapsulated
- Do not infiltrate adjacent tissues
- Do not metastasize
Malignant Tumors
- Rapid or uncontrolled growth
- Poorly circumscribed
- Infiltrative and destructive
- Metastatic potential
- Cause systemic effects (cachexia, anemia)
B. Classification According to Tissue of Origin
1. Epithelial Tumors
- Benign:
- Papilloma
- Adenoma
- Malignant (Carcinomas):
- Squamous cell carcinoma
- Adenocarcinoma
- Basal cell carcinoma
- Transitional cell carcinoma
2. Mesenchymal Tumors
- Benign:
- Lipoma (adipose tissue)
- Fibroma (fibrous tissue)
- Chondroma (cartilage)
- Osteoma (bone)
- Leiomyoma (smooth muscle)
- Malignant (Sarcomas):
- Liposarcoma
- Fibrosarcoma
- Chondrosarcoma
- Osteosarcoma
- Leiomyosarcoma
3. Hematopoietic and Lymphoid Tumors
- Leukemias
- Lymphomas
- Plasma cell tumors (multiple myeloma)
4. Neuroectodermal Tumors
- Gliomas
- Neuroblastoma
- Melanoma
C. Classification According to Degree of Differentiation
- Well differentiated: resembles tissue of origin
- Moderately differentiated
- Poorly differentiated
- Anaplastic:
- Severe pleomorphism
- High mitotic activity
- Loss of normal tissue architecture
D. Classification According to Growth Pattern
- Expansive (pushing margins)
- Infiltrative (finger-like invasion)
- Exophytic (growing outward)
- Endophytic (growing inward)
4. Nomenclature of Tumors
General Rules
- Benign mesenchymal tumors: tissue + "-oma"
- Malignant epithelial tumors: carcinoma
- Malignant mesenchymal tumors: sarcoma
Important Exceptions
- Lymphoma – malignant
- Melanoma – malignant
- Seminoma – malignant
- Hepatoma (hepatocellular carcinoma)
5. Theories of Tumorigenesis (Carcinogenesis)
A. Genetic Mutation Theory (Modern Central Theory)
- Cancer is a genetic disease at the cellular level
- Caused by accumulation of non-lethal mutations affecting genes controlling:
- Cell proliferation
- Cell differentiation
- DNA repair
- Apoptosis
Main Gene Groups Involved
- Oncogenes
- Tumor suppressor genes
- DNA repair genes
B. Oncogenes
Definition
- Oncogenes are mutated or overexpressed forms of normal genes (proto-oncogenes)
- They promote uncontrolled cell proliferation
- Mutation leads to gain of function
Mechanisms of Activation
- Point mutation
- Gene amplification
- Chromosomal translocation
- Increased gene expression
Important Examples of Oncogenes
- RAS
- Encodes GTP-binding signal transduction protein
- Constant activation → continuous growth signaling
- Common in colon, pancreatic, lung cancers
- MYC
- Transcription factor
- Increases cell proliferation and metabolism
- Amplified in lymphomas and solid tumors
- HER2/neu (ERBB2)
- Growth factor receptor
- Amplified in breast and gastric cancer
- BCR-ABL
- Fusion gene from t(9;22) Philadelphia chromosome
- Constitutive tyrosine kinase activity
- Chronic myeloid leukemia
C. Tumor Suppressor Genes
Definition
- Genes that inhibit cell proliferation or promote apoptosis
- Loss of function mutations
- Both alleles usually need to be inactivated ("two-hit hypothesis")
Important Tumor Suppressor Genes
- TP53 (p53)
- "Guardian of the genome"
- Induces cell cycle arrest or apoptosis after DNA damage
- Mutated in >50% of human cancers
- RB (Retinoblastoma gene)
- Controls G1 → S phase transition
- Loss leads to uncontrolled cell cycle progression
- APC (Adenomatous polyposis coli)
- Regulates β-catenin and Wnt signaling
- Mutation leads to colorectal adenomas
- BRCA1 / BRCA2
- DNA repair genes (homologous recombination)
- Loss increases risk of breast and ovarian cancer
D. DNA Repair Gene Defects
- Not directly oncogenic
- Increase mutation rate
- Lead to genomic instability
Examples
- Mismatch repair genes (MLH1, MSH2)
- Defective in Lynch syndrome (HNPCC)
E. Clonal Evolution Theory
- Tumor originates from a single mutated cell
- Progressive genetic instability
- Selection of aggressive subclones
- Explains:
- Tumor heterogeneity
- Drug resistance
F. Viral Theory of Oncogenesis
- Certain viruses induce malignant transformation
- Mechanisms:
- Integration into host genome
- Viral oncogenes
- Chronic inflammation
Examples
- HPV – cervical carcinoma
- EBV – Burkitt lymphoma, nasopharyngeal carcinoma
- HBV / HCV – hepatocellular carcinoma
G. Chemical Carcinogenesis
- Exposure to carcinogenic substances
Types of Carcinogens
- Direct-acting carcinogens
- Indirect-acting (procarcinogens)
Stages
- Initiation
- Promotion
- Progression
H. Physical Carcinogenesis
- Ionizing radiation
- Ultraviolet radiation
- Causes DNA damage and mutations
I. Immunologic Theory
- Immune system normally eliminates transformed cells
- Tumor development occurs when immune surveillance fails
- Tumor immune evasion mechanisms:
- Reduced antigen expression
- Immunosuppressive cytokines
J. Stem Cell Theory
- Tumors arise from tissue stem cells
- Stem cells have:
- Long lifespan
- High proliferative potential
- Explains tumor recurrence and resistance
6. Adenoma–Carcinoma Sequence (Polyp to Cancer Pathway)
Definition
- Stepwise progression from normal epithelium → adenoma → carcinoma
- Classic model for colorectal cancer development
Molecular Stages
- Normal epithelium
- No mutations
- Early adenoma formation
- APC gene mutation
- Activation of Wnt signaling
- Increased β-catenin activity
- Intermediate adenoma
- KRAS oncogene activation
- Increased proliferation
- Late adenoma (high-grade dysplasia)
- Loss of tumor suppressor genes (e.g. SMAD, DCC)
- Carcinoma
- TP53 mutation
- Invasion through basement membrane
Clinical Significance
- Explains rationale for colonoscopic polypectomy
- Early detection interrupts cancer development
- High-yield exam topic
7. Clinical Significance for Surgeons
- Basis for surgical oncology
- Determines:
- Extent of resection
- Margin requirements
- Lymph node management
- Guides adjuvant therapy decisions
- Essential for exam and clinical reasoning
8. Exam-Oriented Key Points
- Tumor growth is autonomous and irreversible
- Carcinoma = epithelial malignancy
- Sarcoma = mesenchymal malignancy
- Metastasis defines malignancy (except locally aggressive tumors)
- Carcinogenesis is a multistep genetic process
9. Summary
- Tumors represent uncontrolled cell proliferation
- Classification is essential for diagnosis and treatment
- Tumorigenesis is multifactorial
- Understanding mechanisms underpins modern surgery and oncology
